Human Plasma with EDTA anticoagulant from Innovative Research was recently used in the following study:
Journal of Affective Disorders, July 2018.
Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study
Nobuki Kuwano, Takahiro A. Kato, Masato Mitsuhashi, Mina Sato-Kasai, Norihiro Shimokawa, Kohei Hayakawa, Masahiro Ohgidani, Noriaki Sagata, Hiroaki Kubo, Takeshi Sakurai, Shigenobu KanbaJournal of Affective Disorders, July 2018.
"...Since our sandwich ELISA method used a combination of 2 different target antibodies, such as anti-SNAP25 as a capture antibody, and anti-CD81, anti-SYP, anti-IL1beta, anti-IL6, anti-IL34, anti-TNFalpha, anti-TNFR1, or anti-OXR as a detection antibody, a purified or recombinant protein was not applicable as a quantification standard. Thus, we first screened various plasma samples obtained from commercial sources (Innovative Research..."
